Trial Profile
The Effect of Safinamide, a Novel Drug for Parkinson's Disease, on Pressor Response to Oral Tyramine: A Randomized, Double-Blind, Clinical Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Oct 2012
Price :
$35
*
At a glance
- Drugs Safinamide (Primary) ; Phenelzine; Selegiline
- Indications Parkinson's disease
- Focus Pharmacodynamics
- Acronyms EudraCT2008-000770-21
- 01 Oct 2012 New trial record